Table 1.
Patients’ characteristics – whole cohort
| Patient characteristics (n=140) | |
|---|---|
| Demographics | |
| Sex – female, n (%) | 61 (43.6) |
| Age (years), median (IQR) | 66 (62–73) |
| Weight (kg), median (IQR) | 70 (60.1–78.9) |
| Marital status, n (%) | |
| Married | 105 (75) |
| Single | 5 (3.6) |
| Widowed | 16 (11.4) |
| Divorced | 14 (10) |
| Disease characteristics, n (%) | |
| Stage at diagnosis, n (%) | |
| 1 | 16 (11.45) |
| 2 | 16 (11.45) |
| 3 | 45 (32.1) |
| 4 | 63 (45) |
| ECOG performance status, n (%) | |
| 0 | 54 (38.6) |
| 1 | 49 (35) |
| ≥2 | 37 (26.4) |
| Low L3SMI (<41 cm2/m2 for females and <53 cm2/m2 for males), n (%) | 92 (65.7) |
| L3SMI (cm2/m2) whole cohort, median (IQR) | 39.88 (26.4–50.82) |
| L3SMI (cm2/m2) – males, median (IQR) | 47.35 (28.76–56.16) |
| L3SMI (cm2/m2) – females, median (IQR) | 37.05 (22.46–43.28) |
| Background diagnoses, n (%) | |
| Ischemic heart disease | 35 (25) |
| Chronic kidney disease | 7 (5) |
| Diabetes mellitus | 27 (19.3) |
| S/P cerebrovascular disease | 8 (5.7) |
| COPD | 18 (12.9) |
| Laboratory parameters | |
| ALT (IU/L), median (IQR) | 17 (12–24) |
| Creatinine (IU/L), median (IQR) | 0.92 (0.82–1.08) |
| Albumin (IU/L), mean±SD | 3.75±0.5 |
| Hemoglobin (IU/L), mean±SD | 12.5±1.7 |
Abbreviations: L3SMI, L3 skeletal muscle index; ALT, alanine aminotransferase; ECOG, Eastern Cooperative Oncology Group; L3SMI, L3 skeletal muscle index.